SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Cipla Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
500087 INE059A01026 346.471431 CIPLA 0.61 113,350.18 30.52 46 2
Quarters :
ParticularsMar 2024(Rs.Cr)Dec 2023(Rs.Cr)Sep 2023(Rs.Cr)
Gross Sales3444.923798.313736.46
Other Operating Income591.74583.02497.98
Other Income 594.98265.36319.24
Total Income4631.644646.694553.68
Total Expenditure 3208.773025.473009.06
PBIDT1422.871621.221544.62
Interest 5.459.066.61
PBDT1417.421612.161538.01
Depreciation136.81135.02179.81
Tax240.18348.69329.81
Fringe Benefit Tax0.000.000.00
Deferred Tax2.0314.31-1.30
Reported Profit After Tax1038.401114.141029.69
Extra-ordinary Items 56.3796.38114.15
Adjusted Profit After Extra-ordinary item982.031017.76915.54
    
EPS (Unit Curr.)12.8614.9914.17
EPS (Adj) (Unit Curr.)12.8614.9914.17
Calculated EPS (Unit Curr.)12.8613.8012.75
Calculated EPS (Adj) (Unit Curr.)12.8613.8012.75
Calculated EPS (Ann.) (Unit Curr.)51.4555.2051.02
Calculated EPS (Adj) (Ann.) (Unit Curr.)51.4555.2051.02
Book Value (Unit Curr.)0.000.000.00
Dividend (%)650.000.000.00
Equity161.47161.47161.47
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)41.3042.6841.34
PBDTM(%)41.1542.4441.16
PATM(%)30.1429.3327.56